1. Abshagen, U.: Effects of pretreatment with spironolactone on pharmacokinetics of 4?-methyldigoxin in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 91?100 (1973)
2. Abshagen, U., Rennekamp, H.: Influence of chronic treatment with spironolactone on its own pharmacokinetics and on the liver function in normals and cirrhotics. International Symposium on Diuretics in Research and Clinics, Bürgenstock 1975. Abstracts: Ed. W. Siegenthaler, pp. 76?79. Karlsruhe: Verlag G. Braun 1975
3. Buck, S. H., Lage, G. L.: Possible mechanism of the prevention of digitoxin toxicity by spironolactone in the mouse. Arch. int. Pharmacodyn. 189, 192?197 (1971)
4. Castle, M. C., Lage, G. L.: Effect of pretreatment with spironolactone, phenobarbital or ?-diethylaminoethyl diphenylpropyl-acetate (SKF 525-A) on tritium levels in blood, heart and liver of rats at various times after administration of (3H) digitoxin. Biochem. Pharmacol. 21, 1449?1455 (1972)
5. Castle, M. C., Lage, G. L.: Enhanced biliary excretion of digitoxin following spironolactone as it relates to the prevention of digitoxin toxicity. Res. Commun. Chem. Path. Pharmacol. 5, 99?108 (1973a)